Immediate Impact
1 from Science/Nature 91 standout
Citing Papers
Chronic kidney disease
2025 Standout
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
2024 Standout
Works of M. Fiolna being referenced
Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations
2017
Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34vs35-37 weeks' gestation
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Fiolna | 387 | 463 | 43 | 64 | 14 | 527 | |
| Hannah Missfelder‐Lobos | 415 | 329 | 46 | 108 | 15 | 557 | |
| Raphael N. Pollack | 373 | 365 | 83 | 70 | 20 | 525 | |
| Caroline Stella | 312 | 399 | 59 | 75 | 15 | 566 | |
| Ruble A. Mason | 301 | 310 | 29 | 96 | 15 | 617 | |
| Kate Navaratnam | 389 | 355 | 50 | 143 | 26 | 583 | |
| Damir Roje | 296 | 272 | 35 | 101 | 30 | 462 | |
| Alexander Frick | 366 | 395 | 23 | 130 | 12 | 516 | |
| Alaa Ebrashy | 425 | 431 | 59 | 94 | 18 | 573 | |
| Paul Ayuk | 381 | 394 | 58 | 46 | 21 | 585 | |
| Ana Cristina Perez Zamarian | 406 | 428 | 45 | 55 | 14 | 575 |
All Works
Loading papers...